dr. G.W.J. (Geert) Frederix Assistant Professor

Department of Public Health, Healthcare Innovation & Evaluation and Medical Humanities (PHM)
Julius Center Research Program Methodology

Contact

Research programs

Child Health

Research Output

Research Output

Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review

Yska Hemmo A F, Elsink Kim, Kuijpers Taco W, Frederix Geert W J, van Gijn Mariëlle E, van Montfrans Joris M 15 Aug 2019 In: Journal of Clinical Immunology. 39, p. 577-591 15 p.

Effectiveness of endoscopic totally extraperitoneal (TEP) hernia correction for clinically occult inguinal hernia (EFFECT): Study protocol for a randomized controlled trial

Roos Marleen M, Verleisdonk Egbert-Jan M M, Sanders Floris B M, Hoes Arno W, Stellato Rebecca K, Frederix Geert W J, Simmermacher Rogier K J, Burgmans Josephina P J, , van Stel HF 18 Jun 2018 In: Trials. 19 7 p.

Health system productivity change in Zambia: A focus on the child health services

Achoki Tom, Kinfu Yohannes, Masiye Felix, Frederix Geert W J, Hovels Anke, Leufkens Hubert G 8 Dec 2016 In: Journal of public health policy. 38, p. 88-104 17 p.

Unremarked or Unperformed?: Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer

de Boer Pieter T, Frederix Geert W J, Feenstra Talitha L, Vemer Pepijn Sep 2016 In: PharmacoEconomics. 34, p. 833-845 13 p.

Patient monitoring: the hidden costs of treatment with antipsychotics

Nederlof Mariëtte, Frederix Geert W J, Stoker Lennart J., van Solinge Wouter W., Egberts Toine C G, Heerdink Eibert R. 1 Aug 2016 In: British Journal of Clinical Pharmacology. 82, p. 570-572 3 p.

Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions

Frederix Gerardus W J, Haji Ali Afzali Hossein, Dasbach Erik J, Ward Robyn L Aug 2015 In: PharmacoEconomics. 33, p. 777-81 5 p.

Drempelwaarde bij vergoeding van nieuwe medicatie: Doelmatigheidsonderzoek en modellering als onmisbare schakels

Frederix Geert W J, Hövels Anke M., Severens Johan L., Raaijmakers Jan A M, Schellens Jan H M 2015 In: Nederlands Tijdschrift voor Geneeskunde. 159

Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review

Frederix Geert, Severens Johan L, Hövels Anke M 2015 In: Expert Review of Pharmacoeconomics and Outcomes Research. 15, p. 675-85 11 p.

Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium

Frederix G W J, Severens J L, Hövels A M, van Hasselt J G C, Hooiveld M J J, Neven P, Raaijmakers J A M, Schellens J H M 2015 In: European Journal of Cancer Care. 24, p. 340-54 15 p.

Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomes

Frederix Gerardus W J, Severens Johan L, Hövels Anke M, Raaijmakers Jan A M, Schellens Jan H M Jan 2012 In: Value in Health. 15, p. 94-105 12 p.

All Research Output (11)

Contact

Research programs

Research Output

Deze website maakt gebruik van cookies